rs1011051

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_018728.4(MYO5C):​c.4296+670C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.511 in 152,010 control chromosomes in the GnomAD database, including 23,474 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 23474 hom., cov: 31)

Consequence

MYO5C
NM_018728.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.45

Publications

11 publications found
Variant links:
Genes affected
MYO5C (HGNC:7604): (myosin VC) Predicted to enable actin filament binding activity and microfilament motor activity. Predicted to be involved in actin filament organization and vesicle transport along actin filament. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
CERNA1 (HGNC:52664): (competing endogenous lncRNA 1 for miR-4707-5p and miR-4767)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.688 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO5CNM_018728.4 linkc.4296+670C>T intron_variant Intron 35 of 40 ENST00000261839.12 NP_061198.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO5CENST00000261839.12 linkc.4296+670C>T intron_variant Intron 35 of 40 1 NM_018728.4 ENSP00000261839.7
MYO5CENST00000559696.1 linkn.496+670C>T intron_variant Intron 2 of 4 5
MYO5CENST00000560809.5 linkn.*3070+670C>T intron_variant Intron 32 of 37 2 ENSP00000453641.1
CERNA1ENST00000821889.1 linkn.176+4755G>A intron_variant Intron 2 of 3

Frequencies

GnomAD3 genomes
AF:
0.511
AC:
77648
AN:
151892
Hom.:
23478
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.559
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.702
Gnomad EAS
AF:
0.229
Gnomad SAS
AF:
0.391
Gnomad FIN
AF:
0.677
Gnomad MID
AF:
0.646
Gnomad NFE
AF:
0.693
Gnomad OTH
AF:
0.536
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.511
AC:
77655
AN:
152010
Hom.:
23474
Cov.:
31
AF XY:
0.507
AC XY:
37639
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.210
AC:
8713
AN:
41460
American (AMR)
AF:
0.483
AC:
7378
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.702
AC:
2432
AN:
3464
East Asian (EAS)
AF:
0.229
AC:
1184
AN:
5168
South Asian (SAS)
AF:
0.392
AC:
1890
AN:
4818
European-Finnish (FIN)
AF:
0.677
AC:
7155
AN:
10568
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.693
AC:
47083
AN:
67950
Other (OTH)
AF:
0.533
AC:
1124
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1559
3118
4677
6236
7795
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.612
Hom.:
14522
Bravo
AF:
0.480
Asia WGS
AF:
0.298
AC:
1037
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.098
DANN
Benign
0.37
PhyloP100
-2.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1011051; hg19: chr15-52503257; API